New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Tenax Therapeutics, Inc.
TENX
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

16M

Biotechnology

Next Earning date - 11 Nov 2024

16M

Biotechnology

Next Earning date - 11 Nov 2024

4.75USD
Shape-0.03 ( -0.63%)
favorite-chart

Relative Strenght

9
favorite-chart

Volume Buzz

-36%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

92%

Quote Panel

Shape
Updated October 26, 2024
1W 17.28 % 1M 36.10 % 3M 41.79 % 1Y -76.53 %

Key Metrics

Shape
  • Market Cap

    16.19M


  • Shares Outstanding

    3.41M


  • Share in Float

    2.98M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    4.75


  • Average Volume

    517968


  • Beta

    2.209


  • Range

    2.77-61.2


  • Industry

    Biotechnology


  • Website

    https://www.tenaxthera.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2796.60x

P/S Ratio

1.05x

P/B Ratio

0.0

Debt/Equity

-85913.8%

Net Margin

$-22.9

EPS

How TENX compares to sector?

P/E Ratio

Relative Strength

Shape

TENX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2M

ShapeNaN%

2025-Revenue

$4.39

Shape-140%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Leerink Partners

initialise

Previous: Not converted

2024-10-24

Now: Outperform

Guggenheim

initialise

Previous: Not converted

2024-10-14

Now: Buy

William Blair

initialise

Previous: Not converted

2024-09-30

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-176.00
vs -240.00

Q4.22

arrow
arrow

N/A

-1.73
vs -0.80

Q1.23

arrow
arrow

N/A

-12.00
vs -176.00

Q2.23

arrow
arrow

N/A

-4.00
vs -176.00

Q3.23

arrow
arrow

N/A

-6.40
vs -176.00

Q4.23

arrow
arrow

N/A

-12.98
vs -1.73

Q1.24

arrow
arrow

N/A

-3.12
vs -12.00

Q2.24

arrow
arrow

N/A

-1.83
vs -4.00

Q3.24

arrow
arrow

N/A

-1.37
vs -6.40

Q4.24

arrow
arrow

N/A

-1.27
vs -12.98

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

5.8K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-221%

-2.21
vs -1.27

Q4.22

arrow
arrow

-170%

-1.70
vs -2.21

Q1.23

arrow
arrow

-30%

-0.30
vs -1.70

Q2.23

arrow
arrow

-8%

-0.08
vs -0.30

Q3.23

arrow
arrow

-17%

-0.17
vs -0.08

Q4.23

arrow
arrow

-40%

-0.40
vs -0.17

Q1.24

arrow
arrow

+31%

0.31
vs -0.40

Q2.24

arrow
arrow

-40%

-0.40
vs 0.31

Institutionnal OwnershipShape

status-upQoQ

Q1.21

arrow
arrow

15

15
vs 16

-6%

Q2.21

arrow
arrow

16

16
vs 15

7%

Q3.21

arrow
arrow

14

14
vs 16

-12%

Q4.21

arrow
arrow

16

16
vs 14

14%

Q1.22

arrow
arrow

15

15
vs 16

-6%

Q2.22

arrow
arrow

15

15
vs 15

NA

Q3.22

arrow
arrow

20

20
vs 15

33%

Q4.22

arrow
arrow

15

15
vs 20

-25%

Earnings Growth

Latest News